StonvexLoading…
StonvexStonvexStonvexCore line items from VRA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-11-01 | Annual 2025 2025-08-02 | Annual 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $269.65M | $62.25M | $70.86M | $51.65M |
Operating Income | $-31.91M | $-34.62M | $-22.45M | $-17.86M |
Net Income | $-47.84M | $-12.37M | $-4.67M | $-33.46M |
EPS (Diluted) | $-1.71 | $-0.44 | $-0.17 | $-1.20 |
Total Assets | $234.00M | $243.68M | $266.18M | $267.94M |
Total Liabilities | $102.37M | $115.62M | $125.69M | $121.91M |
Cash & Equivalents | $18.51M | $10.73M | $15.18M | $11.28M |
Free Cash Flow OCF − CapEx | $-13.26M | $-30.37M | $-25.91M | $-19.77M |
Shares Outstanding | 27.97M | 27.95M | 27.94M | 27.92M |